Alex K Gertner
Biographic Data
| ID | 7449072 |
|---|---|
| NAME | Alex K Gertner |
| GIVEN NAMES | Alex K |
| FAMILY NAME | Gertner |
| SIGNATURE | GERTNER A K |
| AFFILIATIONS | Alexion Pharma (Switzerland) |
| ORCID | 0000-0001-7781-3681 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 1 |
A mixed methods study of provider factors in buprenorphine treatment retention
Science of Uncertainty
Public health efforts around the globe are increasingly dominated by concerns over access to high-cost medicines. These drugs bring new benefits and potential risks to bear on populations and greatly impact government budgets and priorities. This article explores how scientific evidence is being mobilized to inform decisions concerning the incorporation of health technologies in Brazil. I conducted interviews with experts and observed the work of…
Science of Uncertainty
Public health efforts around the globe are increasingly dominated by concerns over access to high-cost medicines. These drugs bring new benefits and potential risks to bear on populations and greatly impact government budgets and priorities. This article explores how scientific evidence is being mobilized to inform decisions concerning the incorporation of health technologies in Brazil. I conducted interviews with experts and observed the work of…
Science of Uncertainty
Public health efforts around the globe are increasingly dominated by concerns over access to high-cost medicines. These drugs bring new benefits and potential risks to bear on populations and greatly impact government budgets and priorities. This article explores how scientific evidence is being mobilized to inform decisions concerning the incorporation of health technologies in Brazil. I conducted interviews with experts and observed the work of…
A mixed methods study of provider factors in buprenorphine treatment retention
Psychology (2 works) · Buprenorphine (1 work) · Business (1 work) · Drug (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · HIV, Drug Use, Sexual Risk (1 work) · Internal Medicine (1 work) · Law (1 work) · Law (1 work) · Medicine (1 work)